Roche, the manufacturer of Tamiflu, has made it impossible for scientists to assess how well the anti-flu drug works by withholding the evidence the company has gained from trials, doctors alleged on Tuesday.
A major review of what data there is in the public domain has found no evidence Tamiflu can prevent healthy people with flu from suffering complications such as pneumonia.
Tamiflu may shorten the bout of illness by a day or so, the investigators say, but it is impossible to know whether it prevents severe disease because the published data is insufficient. Roche has failed to make some of the studies carried out on the drug publicly available, the scientists say.
“Governments around the world have spent billions of pounds on a drug that the scientific community now finds itself unable to judge,” said Fiona Godlee, editor of the British Medical Journal, which published the new review online and collaborated in a joint investigation with Channel 4 News, shown on Tuesday night.
Roche has made a fortune out of the drug, with sales of £1.6 billion this year alone.
In the review, Chris Del Mar, from Bond University in Australia, analyzed 20 published trials that focused on prevention, treatment and adverse reactions. The authors say they were hampered by the “paucity of good data.”
The reviewers were forced to leave out eight trials because they had not been published, and Roche offered them “under conditions we thought unacceptable, and what was offered to us was insufficient to analyze properly.”
As they did not have full access to all the trials, the reviewers say previous evidence on the effects of Tamiflu and other drugs of this class [the neuraminidase inhibitors] may be unreliable. They call on governments to set up studies to monitor the drugs for safety.
A second review was carried out at Birmingham University, England, by Nick Freemantle and Melanie Calvert, who analyzed a series of observational studies Roche provided. These are studies of people who took the drugs, but without a comparison group of people who did not take them.
Although the reviewers had doubts about the data, they say it is possible Tamiflu reduced the risk of pneumonia. But if so, the benefit was small and there were side-effects to consider.
Freemantle said he saw “very little evidence to support the widespread use of oseltamivir in the otherwise healthy population who are developing signs of influenza-like illness.”
He added: “We have remarkably few resources in this country [the UK] to spend on pharmaceuticals on health, and it is surprising to see such widespread use of oseltamivir. But I suppose that once you’ve gone and bought lots of doses, then it’s a bit like the situation with gun control in the US. If you have a gun in the house, it is much easier to use it. But it does not mean it’s the right thing to do.”
Godlee and Mike Clarke, director of the UK Cochrane Centre, call, in the BMJ, for new global legislation to ensure all trial data on drugs that have been granted a licence must be published in full.
Roche said that it firmly believed in the robustness of the data. It said governments and licensing authorities had been given access to all the trial information.
Roche has now undertaken to put summaries of all the Tamiflu study data on a password-protected site.
NO EXCUSES: Marcos said his administration was acting on voters’ demands, but an academic said the move was emotionally motivated after a poor midterm showing Philippine President Ferdinand Marcos Jr yesterday sought the resignation of all his Cabinet secretaries, in a move seen as an attempt to reset the political agenda and assert his authority over the second half of his single six-year term. The order came after the president’s allies failed to win a majority of Senate seats contested in the 12 polls on Monday last week, leaving Marcos facing a divided political and legislative landscape that could thwart his attempts to have an ally succeed him in 2028. “He’s talking to the people, trying to salvage whatever political capital he has left. I think it’s
Polish presidential candidates offered different visions of Poland and its relations with Ukraine in a televised debate ahead of next week’s run-off, which remains on a knife-edge. During a head-to-head debate lasting two hours, centrist Warsaw Mayor Rafal Trzaskowski, from Polish Prime Minister Donald Tusk’s governing pro-European coalition, faced the Eurosceptic historian Karol Nawrocki, backed by the right-wing populist Law and Justice party (PiS). The two candidates, who qualified for the second round after coming in the top two places in the first vote on Sunday last week, clashed over Poland’s relations with Ukraine, EU policy and the track records of their
UNSCHEDULED VISIT: ‘It’s a very bulky new neighbor, but it will soon go away,’ said Johan Helberg of the 135m container ship that run aground near his house A man in Norway awoke early on Thursday to discover a huge container ship had run aground a stone’s throw from his fjord-side house — and he had slept through the commotion. For an as-yet unknown reason, the 135m NCL Salten sailed up onto shore just meters from Johan Helberg’s house in a fjord near Trondheim in central Norway. Helberg only discovered the unexpected visitor when a panicked neighbor who had rung his doorbell repeatedly to no avail gave up and called him on the phone. “The doorbell rang at a time of day when I don’t like to open,” Helberg told television
‘A THREAT’: Guyanese President Irfan Ali called on Venezuela to follow international court rulings over the region, whose border Guyana says was ratified back in 1899 Misael Zapara said he would vote in Venezuela’s first elections yesterday for the territory of Essequibo, despite living more than 100km away from the oil-rich Guyana-administered region. Both countries lay claim to Essequibo, which makes up two-thirds of Guyana’s territory and is home to 125,000 of its 800,000 citizens. Guyana has administered the region for decades. The centuries-old dispute has intensified since ExxonMobil discovered massive offshore oil deposits a decade ago, giving Guyana the largest crude oil reserves per capita in the world. Venezuela would elect a governor, eight National Assembly deputies and regional councilors in a newly created constituency for the 160,000
RSS